Quinupristin + Dalfopristin
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia.
- Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.
NON-FDA APPROVED USES
- Endocarditis (generally not recommended due to poorer clearance of bacteremia)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Patients with serious or life-threatening infections associated with vancomycin-resistant Enterococcus faecium (VREF) bacteremia.
- Complicated skin and skin structure infections caused by Staphylococcus aureus (MSSA) or Streptococcus pyogenes.
NON-FDA APPROVED USES
- Endocarditis (generally not recommended due to poorer clearance of bacteremia)
There's more to see -- the rest of this entry is available only to subscribers.